Five Prime Therapeutics, Inc. (FPRX) was a big mover last session, as the company saw its shares rise by roughly 23% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This continues the recent uptrend of the company as the stock has now gained almost 67% since Mar 3.
This biotechnology company has seen no estimate revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Five Prime Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Five Prime Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the industrial goods sector include Alkermes plc (ALKS), Alexion Pharmaceuticals, Inc. (ALXN) and ANI Pharmaceuticals, Inc. (ANIP).  All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>FIVE PRIME THERAPEUTICS INC (FPRX): Free Stock Analysis ReportALKERMES PLC ORD (ALKS): Free Stock Analysis ReportALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis ReportANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis ReportZacks Investment Research